C40-, C28-, AND C-32-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS

The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.

Saved in:
Bibliographic Details
Main Authors PITZEN Jennifer, WANG Gang, SEMKO Christopher Michael, LEE Julie Chu-Li, KISS Gert, AGGEN James Bradley, GLIEDT Micah James Evans, WON Walter, CREGG James Joseph, THOTTUMKARA Arun P, GILL Adrian Liam, BURNETT G. Leslie, MELLEM Kevin T
Format Patent
LanguageEnglish
Slovenian
Published 31.08.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.
Bibliography:Application Number: SI20190030546T